Sustainable Medicines Manufacturing

The Sustainable Medicines Manufacturing Innovation programme will focus on innovation in pharmaceutical manufacturing to improve the manufacturing innovation ecosystem in the UK towards a sustainable future.

Promoting the long-term viability of the medicines manufacturing industry

Sustainable medicines manufacturing, strives for the production of medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability.

Innovate UK’s Sustainable Medicines Manufacturing programme aims to transform the UK’s medicines manufacturing sector by driving innovation, adoption, investment, and collaboration. The programme will focus on developing disruptive technologies to optimise production efficiency, minimise waste, and reduce emissions, aligning with global sustainability goals. It will promote the adoption of innovative solutions across the sector to ensure scalability and widespread use while enhancing the UK’s attractiveness as a prime location for investment in medicines manufacturing, fostering economic growth and resilience.

By strengthening partnerships among academia, industry, and government, the programme will enhance the UK’s manufacturing innovation ecosystem and promote sustainable practices.

The Sustainable Medicines Manufacturing Innovation programme is funded as part of the wider VPAG Investment Programme agreed as part of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).

Focus areas

The programme will drive collaboration between organisations throughout the medicines manufacturing supply chain to stimulate innovation for sustainability improvements with the alignment to three core pillars as well as two critical enablers: i) regulation, ii) measurements, standards and data.
Green chemistry

PILLAR

Green chemistry

Producing medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability.

Circularity

PILLAR

Circularity

Reducing waste, energy consumption and emissions, while enhancing efficiency, safety, and cost-effectiveness throughout the manufacturing lifecycle.

Productivity

PILLAR

Productivity

Adopting of innovative technologies and practices that promote the long-term viability of the medicines manufacturing industry.


Sustainable Medicines Manufacturing collaboration database

We are building a collaboration database for all competitions within the Sustainable Medicines Manufacturing Innovation Programme. To join the directory of organisations, create and share your collaboration profile detailing your needs and offerings with our team. By participating, you can connect with potential partners, with new collaborators being added each month to expand opportunities.

Download database

Related Opportunities

Launchpad: life and health sciences, Northern Ireland – Round 2 MFA

Opens: 04/11/2024   Closes: 11/12/2024

UK registered businesses can apply for a share of up to £4.3m for innovation activities in the life and health sciences cluster in Northern Ireland.

More Information

Launchpad: life and health sciences, Northern Ireland – Round 2 CR&D

Opens: 04/11/2024   Closes: 11/12/2024

UK registered businesses can apply for a share of up to £4.3m for innovation activities in the life and health sciences cluster in Northern Ireland.

More Information

Investor Partnerships in health technologies, West Yorkshire: Rd 1

Opens: 04/11/2024   Closes: 11/12/2024

Grant funding for SME innovation projects, alongside investment from selected investor partners, in the health technology cluster in West Yorkshire

More Information

Launchpad: bio-based manufacturing, Scotland – Round 2 MFA

Opens: 04/11/2024   Closes: 11/12/2024

UK registered businesses can apply for a share of up to £5.25m to grow their innovation activities in the bio-based manufacturing cluster in Scotland.

More Information

Launchpad: Bio-based Manufacturing, Scotland – Round 2 CR&D

Opens: 04/11/2024   Closes: 11/12/2024

UK registered businesses can apply for a share of up to £5.25m to grow their innovation activities in the bio-based manufacturing cluster in Scotland.

More Information

Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest

EOIs accepted on a rolling basis; quarterly assessments

Capital grants to support investments over £8m in the manufacture of human medicines, medical diagnostics and medtech products; assessed quarterly

More Information

Related Events and Recordings

Thu
25
Jul
2024

Sustainable Medicines Manufacturing Innovation Programme Information Webinar

11.00 - 12.00 GMT | Online

Watch now
Tue
10
Dec
2024

Sustainable bio-based Materials and Manufacture (SusBioMM) Cafes

10.00 - 10.45 | Online

Register for this series
See all events

Our Experts

SUBSCRIBE

Transforming Medicines Manufacturing Community of Practice

Join our collaborative forum to create a dynamic learning environment that promotes active participation and drives forward cutting-edge innovation in medicines manufacturing.

Read more and subscribe

Related programme

Transforming Medicines Manufacturing

Transforming Medicines Manufacturing

Innovate UK’s Transforming Medicines Manufacturing programme aims to drive the de-risking and adoption of highly innovative flexible, agile and scalable manufacturing technologies through a culture of collaboration that will drive the growth of this critically important manufacturing sector.

Close

Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.